INTRODUCTION
The terpenes are secondary metabolites of plants that are produced, in part, as a defense against microorganisms and insects, in addition to being pollinator-attractants 1 . In mammals, terpenes contribute to stabilizing cell membranes, participate in metabolic pathways, and act as regulators of some enzymatic reactions 2 . Members of this class of chemicals have carbon structures that can decomposed into isoprene C 5 H 8 residues and are classified, based on the number of carbons in the molecule, as monoterpenes 10 carbons , sesquiterpenes 15 carbons , diterpenes 20 carbons , triterpenes 30 carbons , and tetraterpenes or carotenes 40 carbons 3 . Simpler terpenes mono-and sesquiterpenes are the major constituents of essential oils and are widely used in the perfumery industry, while diand triterpenes are less volatile and are obtained from plant gums and resins 4 . Carotenes are synthesized by bacteria, algae, fungi, and green plants and comprise more than 600 known structures 5 .
Alzheimer s disease AD is a neurodegenerative disease and the most frequent and predominant cause of dementia in the elderly, provoking progressive cognitive decline, psychobehavioral disturbances, memory loss, the presence of senile plaques, neurofibrillary tangles, and a decrease in cholinergic transmission 6, 7 . Although the pathogenesis of AD is complicated and involves numerous pathways, the two major hypotheses currently under consideration regarding the molecular mechanism are the cholinergic and the amyloid cascade hypotheses. Therefore, the focus of this study is on the inhibitors of select cholinesterases ChEs aimed at alleviating cholinergic deficits and improving neurotransmission. Amyloid β peptide Aβ results from the proteolysis of the amyloid precursor protein APP by β-secretase BACE and γ-secretase, and the formation and accumulation of Aβ is a crucial factor in AD pathogenesis, the β-site APP cleaving enzyme 1 BACE1; aspartyl protease, Asp2, and memapsin 7 has recently emerged as a prevalent therapeutic target for AD 8, 9 .
As part of our continuing search for bioactive natural compounds, we investigated the inhibition of acetylcholinesterase AChE activity by flavor-inducing compounds such as monoterpenes 10, 11 . The present work deals with the inhibition of BACE1 activity by aroma compounds monterpenes, sesquiterpenes, and C 13 norisoprenoids .
MATERIALS AND METHODS

Materials
The recombinant human BACE1 assay kit was purchased from the Pan Vera Co. USA . Terpenes and other chemicals used in this study were purchased from Wako Pure Chemicals Co., Ltd., Tokyo, Japan , Tokyo Chemical Industry Co., Ltd., Tokyo, Japan , Sigma-Aldrich Tokyo, Japan , Nippon Terpene Chemicals, Inc., Hyogo, Japan and Taiyo Perfume Co., Ltd., Osaka, Japan .
BACE1 Enzyme Assay
The assay was carried out according to the supplied manual with modifications 12 . Briefly, a mixture of 10 μL each of assay buffer 50 mM sodium acetate, pH 4.5 , BACE1 1.0 U/mL , the substrate 750 nM Rh-EVNLDAE-FK-Quencher in 50 mM ammonium bicarbonate , and the sample dissolved in 30% dimethyl sulfoxide DMSO was incubated for 60 min at room temperature in the dark. The mixture was irradiated at 550 nm, and the emission intensity was recorded at 590 nm, and the inhibition ratio was calculated using the following equation:
where, C was the fluorescence of the control enzyme, buffer, and substrate after a 60 min incubation, C 0 was the fluorescence of control at time zero, S was the fluorescence of the tested samples enzyme, sample solution, and substrate after incubation, and S 0 was the fluorescence of the tested samples at time 0. To allow for the quenching effect of the samples, their solutions were added to the reaction mixture C, and any reduction in fluorescence by was then determined. All the data are the mean of three experiments. Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-statine -ValAla-Glu-Phe-OH was used as the positive control 12 .
Kinetic parameters for inhibition of BACE1 activities by aroma compounds were estimated by nonlinear regression analysis using the program Graph Pad Prism Graph Pad Prism, San Diego, CA . Table 1 Inhibition of BACE1 by aroma compounds.
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RESULTS AND DISCUSSION
The screening for β-secretase BACE1 inhibition revealed it was inhibited by 80 types of aroma compounds monoterpenes, sesquiterpenes, and C 13 norisoprenoids with a similar potency Table 1 . In the screening experiments, test compounds were used at the maximum concentrations attainable in the assay mixture but were maint
-fenchone, and -fenchone showed substantial BACE1 inhibition. Geranyl acetone, neryl acetone, and β-ionone, which are C 13 norisoprenoids, effectively inhibited BACE1 with half-maximal inhibitory concentration IC 50 values ranging from 51.9 to 198.4 μM. The BACE1 inhibitory effects of most of the C 15 compounds sesquiterpenes were lower than those of the monoterpenes and C 13 norisoprenoids. The most potent inhibitor of BACE1 was geranyl acetone followed by -camphor, -fenchone, -fenchone, and -camphor Figs. 1 and 2 . Geranyl acetone, which strongly inhibited BACE1, was characterized to determine its inhibition kinetics. Dixon plots are extremely useful for determining the inhibition parameters but are not sufficient to fully elucidate the type of inhibition because the Dixon plots for mixed and competitive inhibitions are similar. The complementary Cornish-Bowden plots 13 in which the ratio of the substrate concentration and enzyme activity is plotted versus the inhibitor concentration, allows a distinction to be made between these two types of inhibition. This plot, by itself, is also not sufficient to fully determine the type of inhibition because it has the disadvantage of not always distinguishing between mixed and uncompetitive inhibition. However, by analyzing the two plots together, all types of inhibition can be characterized. Since geranyl acetone inhibited recombinant BACE1 activities, we analyzed the modes and types of inhibition induced by geranyl acetone using Dixon and Cornish-Bowden plots Fig. 3 . The two concentrations of the substrate used were tested using three steps of the inhibitor. The Dixon and CornishBowden plots were then generated from the resulting data sets. The results of the determination of the types of inhibition of BACE1 activities revealed that geranyl acetone exhibited a mixed type inhibition as shown by the plots Fig. 3 . Because K i K i where K i , the inhibition con- Fig. 2 Chemical structures of geranyl acetone, -camphor, -camphor, -fenchone, and -fenchone. geranyl acetone; -camphor; -camphor; -fenchone; -fenchone. stant, is the dissociation constant of the enzyme-substrateinhibitor complex , in both cases, the intersection was above and below the inhibitor concentration axis in the Cornish-Bowden and Dixon plots, respectively 13 .
Terpenes have been reported to have several pharmacological activities, such as antibacterial and antitumor 14, 15 .
Futhermore, in previous studies, monoterpenes have shown inhibitory effects of AChE 10, 11 . Therefore, in the present study, 80 types of aroma compounds including monoterpenes, sesquiterpenes, and C 13 norisoprenoids were screened for their effects on BACE1 activity. Among them, 14 compounds, which were 2-carene, 3-carene, sabinene, -fenchone, -fenchone, -camphor, -camphor, geranyl acetate, citronellyl acetate, dihydromyrcenyl acetate, geranyl acetone, neryl acetone, β-ionone, and cedryl acetate, possessed considerable BACE1 inhibitory activity. Then a series of concentrations were used for the IC 50 determination Table 1 .
These results indicate that aroma compounds could be a possible therapeutic strategy for preventing Alzheimer s disease. Further studies may be required to assess the physiologically relevant exposure levels of these compounds through typical diets and their effects on enzyme inhibition and induction in vivo. Fig. 3 Dixon plots panels A and Cornish-Bowden plots panels B for inhibition of BACE1 activity by g e r a n y l a c e t o n e . T h e B A C E 1 s u b s t r a t e concentrations used were 1500 nM and 750 nM . The results are presented as means S.D. of triplicate experiments.
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